The siRNA against JAG1 reduced cyclin D1 expression and the inhibition of cell cycle progression via cyclin D1-dependent G1/S checkpoint-mediated proliferation in breast cancer cells [35]. The gene discussed is JAG1; the disease is breast carcinoma.